Actinium Pharmaceuticals
Actinium Pharmaceuticals develops alpha particle linked antibodies to treat cancer.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Actinium Pharmaceuticals Information
Geographic Data
Address:
City: New York
State: New York
Zip:
Country: United States
Financial Info
Stage:
post ipo equity
Raised Last:
$25M
Raised Total:$106M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Actinium Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing therapies for life threatening diseases using its alpha particle immunotherapy platform and other related technologies. The company’s principal product candidates include Actimab-A, a Phase I/II clinical trial monoclonal antibody for the treatment of acute myeloid leukemia in elderly patients; and Iomab-B that has completed a Phase I/II design trial used to condition the bone marrow of patients by destroying blood cancer cells in their bone marrow. It also offers BC8-Y-90 and BC8-SA product candidates, which are in physician sponsored clinical phase I trials at the Fred Hutchinson Cancer Research Center. The company was founded in 2000 and is based in New York, New York.
Contact Phone:
Contact Email:
Actinium Pharmaceuticals went public on 6/2/2012 on the NYSEMKT
Listed Exchange:
NYSEMKT
IPO Date:
6/2/2012
Ticker Symbol:
ATNM
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2017 | Post-IPO Equity | $16.1M | 9/2016 | Post-IPO Equity | $10M | 11/2011 | Debt Financing | $364k | 6/2015 | Post-IPO Equity | $5M | 6/2014 | Post-IPO Equity | $11.4M | 4/2020 | Post-IPO Equity | $31.6M | 1/2014 | Post-IPO Equity | $6.6M | 6/2020 | Post-IPO Equity | $25M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
